Related references
Note: Only part of the references are listed.2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients
Christoph Heinz et al.
ANESTHESIOLOGY (2021)
Rationale and design of Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R) study A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
Ying X. Gue et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: An observational cohort study
Christian Roth et al.
PLOS ONE (2020)
Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present
Diana A. Gorog et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study
Wael Sumaya et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Impaired endogenous fibrinolysis at high shear using a point-of-care test in STEMI is associated with alterations in clot architecture
Nikolaos Spinthakis et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation
Nikolaos Spinthakis et al.
EUROPACE (2019)
Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor? JACC Review Topic of the Week
Diana A. Gorog et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Impaired endogenous fibrinolysis in ST-segment elevationmyocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study
Mohamed Farag et al.
EUROPEAN HEART JOURNAL (2019)
Endogenous fibrinolysis in STEMI: important before and after primary PCI
Peter R. Sinnaeve et al.
EUROPEAN HEART JOURNAL (2019)
Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis
Nikolaos Spinthakis et al.
THROMBOSIS RESEARCH (2019)
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
Aaron W. Aday et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
Wael Sumaya et al.
EUROPEAN HEART JOURNAL (2018)
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet TherapyCurrent Data and Future Directions
Nikolaos Spinthakis et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa et al.
LANCET (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation
Mohamed Farag et al.
PLATELETS (2016)
Re-infarction after primary percutaneous coronary intervention
John K. French et al.
CURRENT OPINION IN CARDIOLOGY (2015)
Endogenous Fibrinolysis
Osita N. Okafor et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography
Mauro Panigada et al.
PLOS ONE (2015)
Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study
Linda C. Battes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Fibrin clot properties and their modulation in thrombotic disorders
Anetta Undas
THROMBOSIS AND HAEMOSTASIS (2014)
Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential
J. Yamamoto et al.
THROMBOSIS RESEARCH (2014)
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization The TRILOGY ACS Platelet Function Substudy
Paul A. Gurbel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
Jean-Philippe Collet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
Diana A. Gorog
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction
Smriti Saraf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study
Scott Kinlay et al.
ATHEROSCLEROSIS (2009)
Admission Levels of C-Reactive Protein and Plasminogen Activator Inhibitor-1 in Patients With Acute Myocardial Infarction With and Without Cardiogenic Shock or Heart Failure on Admission
Mehmet Necdet Akkus et al.
INTERNATIONAL HEART JOURNAL (2009)
Premature coronary artery disease in young (age <45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers
Javier Pineda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Chest pain in the emergency room: value of the HEART score
A. J. Six et al.
NETHERLANDS HEART JOURNAL (2008)
Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction
Dimitris Tousoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
Keith A. A. Fox et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Urokinase induced fibrinolysis in thromboelastography: a model for studying fibrinolysis and coagulation in whole blood
MJ Gallimore et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Long-term prognostic value of protein C activity, erythrocyte aggregation and membrane fluidity in transmural myocardial infarction
L Sargento et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Bidirectional relation between inflammation and coagulation
M Levi et al.
CIRCULATION (2004)
Warfarin, aspirin, or both after myocardial infarction.
M Hurlen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina
M Gil et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2002)
D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain
A Bayes-Genis et al.
AMERICAN HEART JOURNAL (2000)
Share Paper
